✦ LIBER ✦

Efficacy of ibandronate for the treatment of skeletal events in patients with metastatic breast cancer

✍ Scribed by P. HERAS; K. KRITIKOS; A. HATZOPOULOS; A.-P. GEORGOPOULOU

Book ID: 108710665
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 104 KB
Volume: 18
Category: Article
ISSN: 0961-5423
DOI: 10.1111/j.1365-2354.2008.00980.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

430 POSTER Efficacy of ibandronate for t

430 POSTER Efficacy of ibandronate for the prevention of skeletal-related events in breast cancer patients with metastatic bone disease

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

1241 POSTER Treatment costs of skeletal-

1241 POSTER Treatment costs of skeletal-related events (SRE) in patients with metastatic breast or prostate cancer

✍ J. Felix; V. Andreozzi; M. Soares; J. Passos-Coelho 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Goals of Treatment for Patients With Met

Goals of Treatment for Patients With Metastatic Breast Cancer

✍ Ian Smith 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Pain reduction with oral and intravenous

Pain reduction with oral and intravenous ibandronate treatment for metastatic bone disease of breast cancer

✍ A.A. Kurth; J. Seraphin; F. Schütze; A. Nusch; I. Schäfer; H. Meden 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Renal Safety of Intravenous Ibandronic A

Renal Safety of Intravenous Ibandronic Acid in Breast Cancer Patients with Metastatic Bone Disease

✍ Dr Nina V. Lyubimova, Nikolay E. Kushlinsky, Michail R. Lichinitser, Karl Schlos 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 114 KB

Intravenous and oral ibandronate reduce

Intravenous and oral ibandronate reduce the risk of skeletal-related events (SREs) in patients with breast cancer and bone metastases

✍ D Tripathy; J.-J Body; I.J Diel; B Bergstrom 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB